We found a beneficial effect of hepatocyte-specific IL11 inhibition on reducing fat deposition and body weight gain in mice on an obesogenic NASH diet, which while notable was not studied in depth. Here, IL11 is linked to metabolic dysfunction-associated steatohepatitis.